Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
RedHill Reports 3Q/2021 Financial Results
-
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results
-
RedHill Biopharma Announces Closing of $15.5 Million Public Offering of American Depositary Shares
-
RedHill Biopharma (RDHL) Prices 4.7M ADS Offering
-
RedHill Biopharma Announces Pricing of $15.5 Million Public Offering of American Depositary Shares
-
RedHill Biopharma (RDHL) Announces ADS Offering, Size not Disclosed
-
RedHill Biopharma Announces Underwritten Public Offering of American Depositary Shares
-
RedHill Biopharma’s (RDHL) Base Business and Pipeline Remain Undervalued - Analyst
-
UPDATE: Cantor Fitzgerald Starts Redhill Biopharma (RDHL) at Overweight
-
RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares
-
RedHill Biopharma Reports 2017 Third Quarter Financial Results
-
RedHill Biopharma (RDHL) Prices 4.1M ADS Offering at $5.50/Sh
-
RedHill Biopharma Prices Public Offering of its American Depositary Shares
-
RedHill Biopharma (RDHL) Plans Offer of ADSs
-
RedHill Biopharma Announces Proposed Public Offering of its American Depositary Shares
-
RedHill Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference
